ERBB2 and breast carcinoma: We suggest that higher sensitivity of this breast cancer cell line was determined by its phenotype; the MDA-MB-231 cell line is classified as triple-negative (estrogen receptor/progesterone receptor/HER2–negative) cell line and is recognized as more prone to cytotoxic treatment because of its lack of DNA repairing capability [30].